Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients.

Helena C W WahnerMalte TrägerKatja BenderLeonille SchweizerJulia OnkenCarolin SengerFelix EhretVolker BudachDavid Kaul

Published in: Radiation oncology (London, England) (2020)

Our model score predicts the OS of patients newly diagnosed with AA and distinguishes patients with a poor survival prognosis from those with a greater life expectancy. Independent and prospective validation is needed. The upcoming changes of the WHO classification of brain tumors as well as the practice changing results from the CATNON trial will most likely require adaption of the score.

Keyphrases

newly diagnosed
end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
clinical trial
healthcare
primary care
machine learning
randomized controlled trial
deep learning
patient reported outcomes
study protocol
open label
quality improvement